ReviewCrit Rev Oncol Hematol2021
The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer.
- Journal
- Crit Rev Oncol Hematol
- Published
- 26 August 2021
- Citations
- 11
- Type
- Review
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try